Sleep Pharmaceuticals Jazz Pharmaceuticals Presents Latest Advancements at World Sleep 2023 October 18, 2023 RTSleepWorld Read Article
Sleep Pharmaceuticals Jazz Showcases Impact of Sleep Medicine Portfolio at Psych Congress 2023 September 12, 2023 RTSleepWorld Read Article
Sleep Pharmaceuticals Jazz to Present New Data at SLEEP 2022 Reinforcing Leadership in Sleep Medicine June 3, 2022 RTSleepWorld Read Article
Study Jazz Pharmaceuticals Presents 18 Abstracts at SLEEP 2021 June 11, 2021 RTSleepWorld Read Article
Sleep Pharmaceuticals Jazz Presents Phase 3 Results of Xywav in Adults with Idiopathic Hypersomnia April 23, 2021 RTSleepWorld Read Article
Vendor News Jazz Pharmaceuticals Announces New Sleep Health Collaboration with AHA September 16, 2020 RTSleepWorld Read Article
Pharmaceuticals Jazz Gets FDA Approval of Xywav for Narcolepsy Related Cataplexy or EDS July 23, 2020 RTSleepWorld Read Article
Pharmaceuticals Jazz Pharmaceuticals Announces FDA Approval of Sunosi for EDS and OSA March 22, 2019 RTSleepWorld Read Article
Pharmaceuticals Jazz Receives New PDUFA Goal Date for Solriamfetol for EDS Associated with Narcolepsy or OSA December 28, 2018 RTSleepWorld Read Article